Alcidion Group Limited (ASX:ALC)
Australia · Delayed Price · Currency is AUD 0.1200
0.00 (0.00%)
Jul 30, 2025, 2:16 PM AEST
Alcidion Group Market Cap
Alcidion Group has a market cap or net worth of 161.15 million as of July 30, 2025. Its market cap has increased by 114.36% in one year.
Market Cap
161.15M
Enterprise Value
154.84M
Revenue
35.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since November 20, 2015, Alcidion Group's market cap has increased from 10.23M to 161.15M, an increase of 1,475.08%. That is a compound annual growth rate of 32.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 161.15M | 100.00% |
| Dec 31, 2024 | 80.58M | -19.97% |
| Dec 29, 2023 | 100.69M | -45.24% |
| Dec 30, 2022 | 183.87M | -45.27% |
| Dec 31, 2021 | 335.99M | 83.32% |
| Dec 31, 2020 | 183.28M | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 131.02B |
| Pro Medicus | 33.47B |
| Cochlear | 20.46B |
| Sonic Healthcare | 13.95B |
| Ramsay Health Care | 8.93B |
| Telix Pharmaceuticals | 7.14B |
| Ansell | 4.47B |
| Mesoblast | 3.19B |